from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2848c/cobB

LFCtreatmentdescriptionclass of inhibitor

-1.444

Amikacinug/mL Amikacintranslation

-1.488

Cap5-10ug/mL Capreomycintranslation

-0.179

Rox10-50 ug/mL Roxithromycintranslation

-0.861

SM2-5 ug/mL Streptomycintranslation

-1.237

Tet5-10 ug/mL Tetracyclinetranslation

0.049

Rif0.2-5ug/mL Rifampicintranscription

0.642

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.766

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.806

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.320

CPZ10-50 ug/mL Chlorpromazinerespiration

1.107

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.108

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.492

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.667

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.519

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.062

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.014

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.532

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.100

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.810

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.036

Nigericin50 uM Nigericinrespiration

-0.252

TRC10-150 ug/mL Triclosanrespiration

0.489

TRZ10-25 ug/mL Thioridazinerespiration

-0.543

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.421

menadione6-10 ug/mL Menadionerespiration

-0.006

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.163

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.578

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.037

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.014

NRP_1Non-replicating persistence stage 1dosRassociated

-0.037

Amp0.2mg/mL AmpicillincellWall

-0.292

Cephalexin20-100 ug/mL CephalexincellWall

-0.262

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.115

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.337

EMB10-20 ug/mL EthambutolcellWall

1.210

Eta12-40 ug/mL EthionamidecellWall

0.589

INH0.2-0.4 ug/mL IsoniazidcellWall

0.575

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.594

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.857

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.787

BZA0.12 mg/mL BenzamidearomaticAmides

-0.395

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.177

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.288

H2O24 mM hydrogen peroxideDNAdamaging

-0.017

Levo10 ug/mL LevofloxacinDNAdamaging

-0.257

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.138

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.237

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.513

UVUV-irradiationDNAdamaging

-0.233

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.099

Antimycin12.5-50 ug/mL Antimycin A?

-0.169

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.265

PA_110-50 ug/mL Antitubercular compound PA-1?

0.204

PA_2110-50 ug/mL Antitubercular compound PA-21?

3.075

PA8240.2-2 ug/mL PA-824?

0.553

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.586

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.508

Verapamil50 uM Verapamil?

0.453

mercaptoethanol2 mM 2-Mercaptoethanol?

0.235

methoxatin10-20 ug/mL Methoxatin?